Dawn Pharma is an oncology drug enterprise with workshops for oral solid dosage and injectable formulations, holding 2 EU marketing authorizations and EU GMP approval. The company has completed development of doxorubicin HCl liposome injection and is seeking authorization, technology transfer and contract manufacturing partnerships.

No comments available.
Leave your rating & comment